NCT06142708View on ClinicalTrials.gov

The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

February 28, 2026

Conditions
Ovarian StimulationHuman Chorionic GonadotropinOocyte Donors
Interventions
DRUG

Dual trigger (human chorionic gonadotropin plus GnRH-agonist)

Human chorionic gonadotropin will be added to GnRH-agonist as a dual trigger in participants previously having had a suboptimal response to GnRH-agonist trigger only

DRUG

GnRH-agonist only trigger

GnRH-agonist only will be used for final maturation

Trial Locations (1)

55133

RECRUITING

Embryolab Fertility Clinic, Thessaloniki

All Listed Sponsors
collaborator

ART Fertility Clinics LLC

OTHER

lead

Embryolab Fertility Clinic

OTHER